1. A novel phosphodiesterase type 4 inhibitor, YM976 (4-(3-chlorophenyl)-1,7-diethylpyrido[2,3-d]pyrimidin-2(1H)-one), with little emetogenic activity;Aoki;J. Pharmacol. Exp. Ther.,2000
2. Antiasthmatic effect of YM976, a novel PDE4 inhibitor, in guinea pigs;Aoki;J. Pharmacol. Exp. Ther.,2001
3. Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor;Aoki;J. Pharmacol. Exp. Ther.,2001
4. Control of human T-lymphocyte interleukin-2 production by a cAMP-dependent pathway;Averill;Cell. Immunol.,1988
5. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation;Bacher;Proc. Natl. Acad. Sci. U. S. A.,1996